Manufacturing news briefs — stories you might have missed

Cyclopharm raises $20 million, seeks another $2 million Radiopharmaceutical imaging company Cyclopharm has successfully completed its institutional placement, raising $20 million before costs. The Placement attracted strong demand from both existing shareholders and from new institutional and sophisticated investors in Australia, Hong Kong, and the UK. A share purchase plan to raise up to $2.0…

A towering energy transition issue: “are we outsourcing this vital work to China?”

The welding industry’s peak body has asked for a “clear and immediate public response” from the federal government on where and when wind and electricity transmission towers will be manufactured. In a statement on Monday, Weld Australia said that the foundational infrastructure enabling the energy transition was being overlooked, and sought confirmation on where the…

Neo-Bionica makes two new board appointments

Medical technology developer and contract manufacturer Neo-Bionica, which announced an investment of $5 million from Breakthrough Victoria earlier this month, has announced two new board appointments. In a statement on Monday, the company said it had added Stéphane Chatonsky and Dr Colin White as non-executive directors. “Their extensive expertise in innovation in MedTech, strategy and…

Best of the week — the five most popular stories among readers, May 20 – May 24, 2024

What were the five biggest stories of the week? Here’s what visitors to @AuManufacturing were reading. 5) New battery strategy to drive battery manufacturing The federal government has released Australia’s first National Battery Strategy, supporting a Future Made in Australia as global demand for batteries is set to quadruple by 2030. According to a joint…